TipRanks
Go Ultimate75% OFF

John Lamattina Insider Profile

4 Followers

John Lamattina, Director at Ligand Pharma, holds 26.97K shares in Ligand Pharma (Ticker: LGND), holds 66.95K shares in Immunome (Ticker: IMNM), holds 31.38K shares in Larimar Therapeutics (Ticker: LRMR). Most recently, John Lamattina Sold ― shares of Ligand Pharma on Jun 12, 2026 for an estimated value of $1.15M.

John Lamattina's Trading History

LGND
Ligand Pharma
Jun 12, 2026DirectorInformative Sell1.15M$8.26M
IMNM
Immunome
Jan 17, 2023DirectorUninformative Buy60.50K$1.25M
LRMR
Larimar Therapeutics
Jan 28, 2019DirectorUninformative Buy47.50K$74.99K
TMO
Thermo Fisher
―Director―$0.00
PFE
Pfizer
―SVP―$13.00M

You May Also Like

John Lamattina insider profile FAQ

What is the percentage of profitable transactions made by John Lamattina?
The percentage of profitable transactions made by John Lamattina is 25%.
What is the average return per transaction made by John Lamattina?
The average return per transaction made by John Lamattina is -31.10%.
What stocks does John Lamattina hold?
John Lamattina holds: LGND, IMNM, LRMR, PFE, TMO stocks.
What was John Lamattina’s latest transaction?
John Lamattina’s latest transaction was an Informative Sell of $1.15M.
What was John Lamattina's most profitable transaction?
John Lamattina’s most profitable transaction was an Informative Sell of LGND stock on November 17, 2021. The return on the trade was 25.00%.
What is John Lamattina's role in Ligand Pharma?
John Lamattina's role in Ligand Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.